4.5 Article

Anti-hepatitis B virus lignans from the root of Streblus asper

期刊

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
卷 23, 期 7, 页码 2238-2244

出版社

PERGAMON-ELSEVIER SCIENCE LTD
DOI: 10.1016/j.bmcl.2013.01.046

关键词

Streblus asper; Moraceae; Strebluslignanol F; (7 ' R,8 ' S,7 '' R,8 '' S)-erythro-Strebluslignanol G; anti-HBV

资金

  1. National Natural Science Foundation of China [20862002]
  2. Natural Science Foundation of Guangxi Province [0832005, 2010GXNSFF013001, 07109001-01]
  3. Foundation of Key Laboratory of Ecology of Rare
  4. Endangered Species and Environmental Conservation
  5. Ministry of Education of China [1001k010]

向作者/读者索取更多资源

Four new lignans, strebluslignanol F (1), (7'R,8'S,7 '' R,8 '' S)-erythro-strebluslignanol G (2), isomagnaldehyde (3) and isostrebluslignanaldehyde (4), along with 12 known lignans (5-16) were isolated from the ethyl acetate-soluble part of MeOH extract of the root of Streblus asper. Their structures were elucidated through various spectroscopic methods, including 1D NMR (H-1 NMR, C-13 NMR), 2D NMR (HMQC, HMBC and NOESY) and HRMS. The stereochemistry at the chiral centers was determined using CD spectra, as well as analyses of coupling constants and optical rotation data. The isolated lignans were evaluated for their anti-HBV activities in vitro using the HBV transfected HepG2.2.15 cell line. The most active lignans, (7'R,8'S,7 '' R,8 '' S)-erythro-strebluslignanol G, magnolol, isomagnolol and isolariciresinol, exhibited significant anti-HBV activities with IC50 values of 1.58, 2.03, 10.34 and 3.67 mu M, respectively, for HBsAg with no cytotoxicity, and of 3.24, 3.76, 8.83 and 14.67 mu M, respectively, for HBeAg with no cytotoxicity. (7'R,8'S,7 '' R,8 '' S)-erythro-Strebluslignanol G and magnolol showed significant anti-HBV activities to inhibit the replication of HBV DNA with the IC50 values of 9.02 and 8.67 mu M, respectively. (C) 2013 Elsevier Ltd. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据